Intraoperative Transfusion Practice in Children

August 23, 2021 updated by: Dr. Florian Piekarski, Johann Wolfgang Goethe University Hospital

A Retrospective Analysis of Perioperative Transfusion Management in Children

The purpose of this study is to examine factors, impact and outcome on perioperative blood transfusion for pediatric patients.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

66

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Germany
    • NRW
      • Frankfurt, NRW, Germany, 60598
        • Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 second to 17 years (Child)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All pediatric patients being operated an receiving transfusion will be included.

Description

Inclusion Criteria:

  • Operation
  • Anaesthesia
  • Transfusion (pRBC, plasma or platelets)

Exclusion Criteria:

  • No

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of children being transfused intraoperative
Time Frame: 01.04.2018 to 31.10.2019
Amount of transfused pRBC, plasma, thrombocytes will be evaluated in children undergoing surgery
01.04.2018 to 31.10.2019
Documented transfusion indication
Time Frame: 01.04.2018 to 31.10.2019
Physiologic transfusion triggers will be evaluated (Hb Level, lactate, venous O2 saturation, levels of catecholamines)
01.04.2018 to 31.10.2019

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Johann Wolfgang Goethe University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2020

Primary Completion (Actual)

October 1, 2020

Study Completion (Actual)

October 15, 2020

Study Registration Dates

First Submitted

February 17, 2020

First Submitted That Met QC Criteria

February 21, 2020

First Posted (Actual)

February 24, 2020

Study Record Updates

Last Update Posted (Actual)

August 24, 2021

Last Update Submitted That Met QC Criteria

August 23, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • KGU_FP_2020_CA5

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Transfusion

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malta

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe